Skip to main content
SpringerLink
Log in

RBC transfusion is “justified on clinical and health economic grounds” for patients with cancer-related anaemia,

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Norum J, Moen M-AN.Practice and costs of red blood cell (RBC) transfusion in an oncological unit. Anticancer Research 28: 459-464, No. 1, Jan-Feb 2008

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

RBC transfusion is “justified on clinical and health economic grounds” for patients with cancer-related anaemia,. Pharmacoecon. Outcomes News 551, 7 (2008). https://doi.org/10.2165/00151234-200805510-00021

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200805510-00021

Keywords

Search

Navigation